Michelle S.
- Country
- Portugal
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 65 partner sites.
Specializations
Oncology Research
The investigator specializes in advanced treatment approaches for metastatic non-small cell lung cancer, with particular emphasis on innovative immunotherapy combinations.
- Lung Cancer Therapeutics
- Immunotherapy Combinations
- Metastatic Disease Management
Key focus includes evaluation of novel therapeutic strategies incorporating immune checkpoint inhibitors for treating advanced lung malignancies.
Immunotherapy Applications
Expertise centers on investigating combination immunotherapy approaches in oncology, particularly exploring the clinical potential of emerging antibody therapeutics.
- Checkpoint Inhibitor Therapy
- Combination Treatment Strategies
- Biomarker Assessment
Special interest in PD-L1 expression analysis and its implications for treatment selection in advanced cancer care.
Therapeutic Innovation
The investigator focuses on developing personalized treatment approaches through comparative analysis of various immunotherapy combinations with chemotherapy.
- Treatment Optimization
- Survival Outcomes
- Patient Selection Strategies
Emphasis on evaluating therapeutic efficacy in advanced cancer treatment through innovative drug combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.